Please login to the form below

Not currently logged in
Email:
Password:

Biotech profile

This page shows the latest Biotech profile news and features for those working in and with pharma, biotech and healthcare.

Sanofi set to acquire Kiadis for €308m

Sanofi set to acquire Kiadis for €308m

Acquisition will see French pharma gain access to NK-cell platform. French pharma Sanofi is set to buy Kiadis for a total of 308 ($358m) for access to the biotech’s ... We believe this transaction represents compelling value to shareholders and offers

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    Tom Evans. Pharma Market Europe talks to its chief executive Tom Evans, a veteran research and business leader in viral diseases, with experience across academia, big pharma and biotech. ... potential to fulfil this target profile.

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines. ... and sustainable clinical pipeline and a robust product engine by the end of 2020; a company profile rarely, if ever, achieved in

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....